Epidemiology and risk factors of urothelial bladder cancer.

By M. Burger, J. Catto, G. Dalbagni, H. Grossman, H. Herr, P. Karakiewicz, W. Kassouf, L. Kiemeney, C. la Vecchia, S. Shariat and 1 more. European Urology, 2013

2,045 citations recorded by the source corpus.

Subfields: Dermatology, Endocrine and Autonomic Systems, Surgery

View Paper: https://www.semanticscholar.org/paper/1f2bbf420d6eec11d873750655def9df009fdd8f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. M. Burger
2. M. Rouprêt
3. M. Babjuk
4. B. V. van Rhijn
5. S. Shariat
6. R. Sylvester

Citations in the corpus

• Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. (2017, neutral): “For example, slow acetylation of N-acetyltransferase 2, a key enzyme in aromatic amines metabolism, is considered to increase susceptibility to tobacco smoke, polycyclic aromatic hydrocarbons, or other occupational carcinogens [2].”
• EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (2017, background): “The incidence and mortality of BCa has decreased in some registries, possibly reflecting the decreased impact of causative agents [3].”
• European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. (2019, background): “While family history seems to have little impact [6], genetic predisposition has an influence on the incidence of BC via its impact on susceptibility to other risk factors [2,7].”
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. (2013, background): “Schistosomiasis is a cause of BCa, particularly squamous cell carcinoma [6] (LE: 3).”
• Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. (2016, background): “[26] Burger M, Catto JW, Dalbagni G, et al.”